131 related articles for article (PubMed ID: 23458173)
1. Efficacy and safety of leflunomide in treatment of steroid-dependent and steroid-resistant adult onset minimal change disease.
Zhou J; Zhang Y; Liu G; Li J; Xu R; Huang J
Clin Nephrol; 2013 Aug; 80(2):121-9. PubMed ID: 23458173
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
Li H; Shi X; Shen H; Li X; Wang H; Li H; Xu G; Chen J
Clin Ther; 2012 May; 34(5):1112-20. PubMed ID: 22503105
[TBL] [Abstract][Full Text] [Related]
3. Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
Waldman M; Crew RJ; Valeri A; Busch J; Stokes B; Markowitz G; D'Agati V; Appel G
Clin J Am Soc Nephrol; 2007 May; 2(3):445-53. PubMed ID: 17699450
[TBL] [Abstract][Full Text] [Related]
4. Leflunomide plus oral prednisone in treatment of idiopathic membranous nephropathy: a retrospective clinical study of efficacy and safety.
Yang S; Xie L; Xue W; Yin A; Lu W
Nephrology (Carlton); 2013 Sep; 18(9):615-22. PubMed ID: 23889815
[TBL] [Abstract][Full Text] [Related]
5. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
[TBL] [Abstract][Full Text] [Related]
7. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
Metzler C; Miehle N; Manger K; Iking-Konert C; de Groot K; Hellmich B; Gross WL; Reinhold-Keller E;
Rheumatology (Oxford); 2007 Jul; 46(7):1087-91. PubMed ID: 17519271
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus improves proteinuria remission in adults with cyclosporine A-resistant or -dependent minimal change disease.
Xu D; Gao X; Bian R; Mei C; Xu C
Nephrology (Carlton); 2017 Mar; 22(3):251-256. PubMed ID: 28035723
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of leflunomide combined with prednisone in the treatment of refractory nephrotic syndrome.
Liu Y; Qu X; Chen W; Zhang Y; Liu L
Ren Fail; 2016 Nov; 38(10):1616-1621. PubMed ID: 27819170
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
Ueda N; Takahashi K; Akioka Y; Morooka M; Ogawa A; Tsuzuki K
J Nephrol; 2009; 22(5):610-5. PubMed ID: 19809993
[TBL] [Abstract][Full Text] [Related]
11. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
Kremer J; Genovese M; Cannon GW; Caldwell J; Cush J; Furst DE; Luggen M; Keystone E; Bathon J; Kavanaugh A; Ruderman E; Coleman P; Curtis D; Kopp E; Kantor S; Weisman M; Waltuck J; Lindsley HB; Markenson J; Crawford B; Fernando I; Simpson K; Strand V
J Rheumatol; 2004 Aug; 31(8):1521-31. PubMed ID: 15290730
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate plus leflunomide for the treatment of relapsingWegener's granulomatosis. A retrospective uncontrolled study.
Bremer JP; Ullrich S; Laudien M; Gross WL; Lamprecht P
Clin Exp Rheumatol; 2010; 28(1 Suppl 57):67-71. PubMed ID: 20412706
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive therapy prevents recurrent pericarditis.
Marcolongo R; Russo R; Laveder F; Noventa F; Agostini C
J Am Coll Cardiol; 1995 Nov; 26(5):1276-9. PubMed ID: 7594043
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
Li X; Li H; Chen J; He Q; Lv R; Lin W; Li Q; He X; Qu L; Suya W
Nephrol Dial Transplant; 2008 Jun; 23(6):1919-25. PubMed ID: 17911091
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial.
Ren H; Shen P; Li X; Pan X; Zhang W; Chen N
Am J Nephrol; 2013; 37(1):84-90. PubMed ID: 23343906
[TBL] [Abstract][Full Text] [Related]
16. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome.
Nakayama M; Katafuchi R; Yanase T; Ikeda K; Tanaka H; Fujimi S
Am J Kidney Dis; 2002 Mar; 39(3):503-12. PubMed ID: 11877569
[TBL] [Abstract][Full Text] [Related]
17. Short-term effect of leflunomide in patients with Takayasu arteritis: an observational study.
de Souza AW; da Silva MD; Machado LS; Oliveira AC; Pinheiro FA; Sato EI
Scand J Rheumatol; 2012 May; 41(3):227-30. PubMed ID: 22400913
[TBL] [Abstract][Full Text] [Related]
18. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis.
Koldingsnes W; Nossent JC
J Rheumatol; 2003 Jan; 30(1):80-8. PubMed ID: 12508394
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of remission with leflunomide in Wegener's granulomatosis.
Metzler C; Fink C; Lamprecht P; Gross WL; Reinhold-Keller E
Rheumatology (Oxford); 2004 Mar; 43(3):315-20. PubMed ID: 14963200
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease.
Qin J; Yang Q; Tang X; Chen W; Li Z; Mao H; Jiang Z; Huang F; Yu X
Clin Nephrol; 2013 Jan; 79(1):37-44. PubMed ID: 22948116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
